Connect with us

Hi, what are you looking for?

Prime Webinar GroupPrime Webinar Group

Tech News

You can get an at-home flu ‘shot’ starting next year

Orange County Register Archive
The at-home treatment could assist people who are unable to travel to immunization appointments. | Photo by Jeff Gritchen/Digital First Media/Orange County Register via Getty Images

The Food and Drug Administration has approved a nasally-administered influenza immunization treatment that can be taken at home. FluMist — a nasal spray vaccine that AstraZeneca initially developed as an in-office treatment two decades ago — will still require a prescription to obtain and is expected to be made available via a new online pharmacy next year, according to The New York Times.

The treatment will require people to fill out a questionnaire on the upcoming FlueMist Home website. Once approved by a pharmacist, the nasal spray will be shipped directly to the customer’s door. The current out-of-pocket cost is around $35 to $45 per dose according to the NYT, but that may drop depending on insurance coverage.

The Centers for Disease…

Continue reading…

You May Also Like

Editor's Pick

Clark Packard The US-China relationship is the most important and complex bilateral relationship in the world today. How these two superpowers interact is a...

Editor's Pick

Adam N. Michel Tax policy has taken on an outsized role in this year’s presidential campaign and was mentioned repeatedly in the recent presidential...

Editor's Pick

So the first Fed rate cut is behind us, and we are no longer in a “higher for longer” period, but in a new...

Editor's Pick

David Inserra Last week, Australia dropped its revised Combatting Misinformation and Disinformation Bill 2024, and it’s about two sandwiches short of a picnic. The...